Savara SVRA
NASDAQ SVRA
$4.55 -0.12 (-2.57%)
As of: Oct 22, 2026 · 12:53 PM EDT

Savara (SVRA) EBT Margin (2015 - 2026)

Updated

Savara (SVRA) reported EBT Margin of -1301200.00% for Q4 2020, down 1296987.11 percentage points from the prior quarter.

Analysis

Savara (SVRA) EBT Margin (2015 - 2026) Analysis & Trends

For FY2020, Savara posted EBT Margin of -19182.88%.

  • EBT Margin has a five-year change of -2518.06 percentage points (FY2015 to FY2020).
  • By year, EBT Margin came in at -2820.00% in FY2016 (+13844.81 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn 26.66%
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn 25.18%
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn -4.11%
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn 29.63%
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn 18.19%
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn 27.53%
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn -131.41%
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn -4.34%
10 Savara 1.15 Bn 415.26 Mn - -4,941.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,941.50%
Mar 31, 2026 -3,688.74%
Dec 31, 2025 -2,796.57%
Sep 30, 2025 -5,520.99%
Jun 30, 2025 -3,413.68%
Mar 31, 2025 -1,778.30%
Dec 31, 2024 -1,629.59%
Sep 30, 2024 -1,238.00%
Dec 31, 2023 -1,160.63%
Dec 31, 2022 -1,771.17%
Dec 31, 2020 -1,301,200.00%
Sep 30, 2020 -4,212.89%
Sep 30, 2019 -248,060.00%
Jun 30, 2019 -70,770.97%
Dec 31, 2018 -11,124.79%
Sep 30, 2018 -11,315.32%
Mar 31, 2017 -5,543.62%
Dec 31, 2016 -1,081.25%
Sep 30, 2016 -7,171.11%
Dec 31, 2015 -22,520.37%
API Access

Savara EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY